• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外用双氯芬酸凝胶治疗播散性浅表性光化性汗孔角化症:病例系列

Treatment of disseminated superficial actinic porokeratosis with topical diclofenac gel: a case series.

作者信息

Vlachou C, Kanelleas A I, Martin-Clavijo A, Berth-Jones J

机构信息

Department of Dermatology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.

出版信息

J Eur Acad Dermatol Venereol. 2008 Nov;22(11):1343-5. doi: 10.1111/j.1468-3083.2008.02842.x. Epub 2008 Jun 11.

DOI:10.1111/j.1468-3083.2008.02842.x
PMID:18554227
Abstract

Disseminated superficial actinic porokeratosis (DSAP) is the most common of the of five clinical variants of porokeratosis. These are disorders of keratinization and the distinctive pathological feature is the cornoid lamella at the margin. DSAP usually manifests in the third or fourth decades of life with a female preponderance and with multiple lesions over sun-exposed areas. A diverse range of treatments is employed though evidence of efficacy remains largely anecdotal. We report a series of eight patients with DSAP treated with 3% diclofenac gel (Solaraze gel).

摘要

播散性浅表性光化性汗孔角化症(DSAP)是汗孔角化症五种临床变型中最常见的一种。这些是角化异常性疾病,其独特的病理特征是边缘处的鸡眼样板。DSAP通常在生命的第三个或第四个十年出现,女性居多,且在暴露于阳光的部位有多个皮损。尽管疗效证据大多是传闻,但仍采用了多种治疗方法。我们报告了一系列8例用3%双氯芬酸凝胶(索拉瑞兹凝胶)治疗的DSAP患者。

相似文献

1
Treatment of disseminated superficial actinic porokeratosis with topical diclofenac gel: a case series.外用双氯芬酸凝胶治疗播散性浅表性光化性汗孔角化症:病例系列
J Eur Acad Dermatol Venereol. 2008 Nov;22(11):1343-5. doi: 10.1111/j.1468-3083.2008.02842.x. Epub 2008 Jun 11.
2
Diclofenac sodium 3% gel as a potential treatment for disseminated superficial actinic porokeratosis.3%双氯芬酸钠凝胶作为播散性浅表光化性汗孔角化症的一种潜在治疗方法。
J Eur Acad Dermatol Venereol. 2009 Jan;23(1):42-5. doi: 10.1111/j.1468-3083.2008.02943.x.
3
Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze).3.0%双氯芬酸钠外用凝胶(Solaraze)治疗光化性角化病的IV期开放标签评估
J Drugs Dermatol. 2004 Jul-Aug;3(4):401-7.
4
Topical diclofenac 3% gel plus cryotherapy for treatment of multiple and recurrent actinic keratoses.外用3%双氯芬酸凝胶联合冷冻疗法治疗多发性和复发性光化性角化病。
Clin Exp Dermatol. 2009 Jan;34(1):33-5. doi: 10.1111/j.1365-2230.2008.02783.x. Epub 2008 Jun 25.
5
Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.一项随机、安慰剂对照的研究,评估 3%双氯芬酸凝胶外用治疗多发性光化性角化病器官移植患者的安全性和疗效。
Eur J Dermatol. 2010 Jul-Aug;20(4):482-8. doi: 10.1684/ejd.2010.1010. Epub 2010 May 27.
6
Genital porokeratosis: treatment with diclofenac topical gel.生殖器汗孔角化症:用双氯芬酸外用凝胶治疗。
J Dermatolog Treat. 2007;18(3):188-90. doi: 10.1080/09546630701258101.
7
Topical diclofenac: new preparation. Moderate efficacy in actinic keratosis.外用双氯芬酸:新制剂。对光化性角化病疗效中等。
Prescrire Int. 2004 Aug;13(72):138-9.
8
Diclofenac sodium 3% gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety.3%双氯芬酸钠凝胶治疗光化性角化病:10多年疗效与安全性的累积证据
J Drugs Dermatol. 2012 May;11(5):600-8.
9
Management of actinic cheilitis using diclofenac 3% gel: a report of six cases.使用3%双氯芬酸凝胶治疗光化性唇炎:6例报告。
Br J Dermatol. 2007 May;156 Suppl 3:43-6. doi: 10.1111/j.1365-2133.2007.07863.x.
10
Disseminated superficial actinic porokeratosis (DSAP): significant improvement after local administration of calcipotriol/betamethasone gel?播散性浅表性光化性汗孔角化症(DSAP):局部应用卡泊三醇/倍他米松凝胶后有显著改善?
Wien Med Wochenschr. 2017 Mar;167(3-4):85-88. doi: 10.1007/s10354-016-0484-8. Epub 2016 Jul 28.

引用本文的文献

1
Disseminated Superficial Actinic Porokeratosis: A Systematic Treatment Review.播散性浅表性光化性汗孔角化症:系统治疗综述
Am J Clin Dermatol. 2025 Jan;26(1):7-21. doi: 10.1007/s40257-024-00903-x. Epub 2024 Nov 1.
2
Porokeratoses: an update on pathogenesis and treatment.汗孔角化症:发病机制与治疗的最新进展
Int J Dermatol. 2025 Jan;64(1):62-71. doi: 10.1111/ijd.17411. Epub 2024 Aug 11.
3
Porokeratoses-A Comprehensive Review on the Genetics and Metabolomics, Imaging Methods and Management of Common Clinical Variants.汗孔角化症——关于常见临床变异型的遗传学、代谢组学、成像方法及管理的综合综述
Metabolites. 2023 Nov 26;13(12):1176. doi: 10.3390/metabo13121176.